Now tracking the new emerging South Africa Omicron Variant |
Sad No HIV Cure |
Post Reply |
Author | |
Guests
Guest Group |
Post Options
Thanks(0)
Posted: January 03 2014 at 3:57pm |
From the Drudge Report: Relapse of ‘cured’ HIV patients
I was hoping for a cure for HIV. It is not just a "gay" virus many people have this for many reasons and it is a killer. Docs thought that a bone marrow transplant had killed the virus but when the patients stopped the suppressing drugs the virus came back or was just hanging so low they could not see it. If you have kids this is bad news because as we all know kids in their teen years start with having sex and this HIV is out there. I hope they find a cure! |
|
Kilt2
Adviser Group Joined: December 17 2007 Status: Offline Points: 7414 |
Post Options
Thanks(0)
|
There is a HIV cure.
Its called prevention. It means putting the brain in gear before the pelvis.
|
|
And I looked, and behold a pale horse: and his name that sat on him was Death, and Hell followed with him.
|
|
Guests
Guest Group |
Post Options
Thanks(0)
|
LOL, you sound like my 90 year old Mama! I think you are both right but kids put the pelvis in gear before the brain!
|
|
jacksdad
Executive Admin Joined: September 08 2007 Location: San Diego Status: Offline Points: 47251 |
Post Options
Thanks(0)
|
FluMom - the problem with finding a cure for HIV is it's mutation rate. In that respect, it even beats influenza.
|
|
"Buy it cheap. Stack it deep"
"Any community that fails to prepare, with the expectation that the federal government will come to the rescue, will be tragically wrong." Michael Leavitt, HHS Secretary. |
|
waterboy
Guest Group |
Post Options
Thanks(0)
|
This company claims to have the cure for AIDS/HIV/Cancer?
www.artec-inc.net |
|
waterboy
Guest Group |
Post Options
Thanks(0)
|
TUBERCINTM Successes "Medicine with Love from Daegu saved a Greek" Medicine with love from Daegu saved a Greek By Chang-Hwan Lee, Athens, August 28, 2004 A beautiful relationship between an old medical professor in Daegu and an eminent physicist from Athens National University is the talk of the town with a glad impression in Athens where the Olympics is being held. It happened between professor Tai-Ho Chung aged seventy one, an emeritus professor of School of Medicine, Kyungpook National University and Professor Manousakis Arkadios aged fifty of the Physics Department, Athens National University. Their special relationship started in last February when professor Manousakis Arkadios was looking all over the world for new treatment to heal his son well. His son aged seventeen was suffering from a rareness disease, Desmoplastic Round cell Tumor which just two hundred patients fall victim to all over the world. His son relapsed into it at the end of last year. He became sick in 2000 and had been treated with several operations and medications in the U.S. and England. However, his condition never took a turn for the better and those medications were not constitutionally suitable for him. Due to severe pain he could not even walk and also suffered from sudden abdominal dropsy. His father, professor Manousakis Arkadios, made every effort to find a way to treat his son and finally found professor Tai-Ho Chung’s anticancer immunotherapy which improves immune surveillance of white blood cell against cancer cell from an American medical journal published in 2002 through the website. He could reached professor Chung through the Korean embassy and appealed to professor Chung with help. Professor Chung felt sympathy by his heartfelt letter as a fellow profession and invited him with his son to Kyungpook National University Hospital for his treatment, but Korea was too far to travel for his weak son. Professor Chung determined to send his therapy to Athens and began to supply the injections to an utter stranger, professor Manousakis Arkadios since last March. Both a blue-eyed physicist holding his critically ill son and a Korean old medical researcher who had devoted his life in medical research and education tried to save a young life together without seeing each other. Finally, their endeavor did wonders, his son who seemed never to take a turn for the better before grew better after a month daily injection. His abdominal dropsy began to flow off with relief from pain. They had exchanged so many fax letters loaded informations with encouragement. Now, his son, Vasilios-loannis, gained in weight of 9 kilogram from 50 kilogram at the time of recurrence. He is restored to health enough to support athletic team during the Olympics. Vasilios-loannis said, “I has recovered to the 70% of normal state, I don’t feel any fatigue after moving much. I hope to be a novel writer someday…”, in an interview with our reporter at his home. Professor Manousakis Arkadios added, “All I can say is that I am thankful to Dr. Chung. He has helped us as a medical doctor and also made a deep impression on us with his humanity”. He earnestly asked us to send his gratitude to Dr. Chung. At the good news of Vasilios-loanni’s recovery, professor Chung mentioned with pleasant smile, “Although I have never met professor Manousakis Arkadios, I believe a karma relations from a previous life with him when I saw his family picture. I am very glad to hear that and will do every effort for his son’s recovery”. 26-year old woman is breast cancer free after treatments with TUBERCINTM. TUBERCINTM treatments help 77-year old woman become melanoma free. See video below. VIDEO TUBERCINTM treatments help 77-year old woman become melanoma free. (To view controls, place mouse over video.) TUBERCINTM as an immunostimulant (Research and treatment of malignant tumors) |
|
Fitz
Guest Group |
Post Options
Thanks(0)
|
Pharmaceutical Firm, ARTEC, Inc., Announces Testing Launch
of TUBERCIN(TM) -- Mission Focus is on the Testing of HIV/AIDS & Tuberculosis Patients in South Africa Monday September 24, 7:01 am ET OKLAHOMA CITY--(BUSINESS WIRE)--ARTEC, Inc., (Pink Sheets: ATKJ - News), visionary pharmaceutical firm, has acquired the preliminary outline to be used for the testing protocol from a sponsoring scientific group in South Africa for TUBERCIN(TM), a revolutionary polysaccharide compound to be used as an HIV/AIDS and ANTI-CANCER immunostimulant. "We are grateful to further test the medicinal impact of TUBERCIN(TM) in South Africa on their suffering patients," said Mr. Gerry Knight, Executive Vice- President of ARTEC, Inc. "Their dedicated partnership is enabling the launch testing of an immunostimulant we believe will greatly impact the devastation of HIV/AIDS, Tuberculosis and cancer worldwide. The continued assistance from our shareholders will also uphold our commitment to speedily developing TUBERCIN(TM) as a treatment that could soon bring hope to the millions suffering." Early in October 2006, Dr. Ronald Shinn, President and Board of Directors Chairman of ARTEC, Inc. arrived in South Africa at the invitation of a group of prominent business and professional South Africans. Although previous in depth communications had occurred, the trip enabled both sides the face-to-face opportunity to explore the use of TUBERCIN(TM) on the devastating impact of HIV/AIDS in Africa. The problem of AIDS is horrendous especially when witnessing it first hand. The Desperate Need for Relief of HIV/AIDS and Tuberculosis in South Africa is currently experiencing one of the most severe HIV/AIDS epidemics in the world. As reported by the World Health Organization, HIV and Tuberculosis form a lethal combination each speeding the other's progress. By the end of 2005, there were five and a half million people living with HIV in South Africa, and almost 1,000 AIDS deaths occurring every day. The Company, together with the cooperation of Mr. Rodney Watson, Director of ARTEC, Inc. South Africa, has assembled a team of scientific personnel necessary for the South Africa FDA project. Emerging as the chief scientist for ARTEC, Inc. is Dr. Shawn Pruitt from the U.S.A. Dr. Pruitt and his colleagues have been working diligently in the development of information and materials on research needed for this project. Recently, ARTEC, Inc. received the preliminary outline of the Testing Protocol to be used from the sponsoring scientific group in South Africa. It is advocating the testing of TUBERCIN(TM) on human patients in the hospital afflicted with AIDS and Tuberculosis. The testing will begin with under 100 patients. ARTEC, Inc. |
|
waterboy
Guest Group |
Post Options
Thanks(0)
|
Pharmaceutical Firm, ARTEC, Inc., Announces Key
Appointments -- Leading Product Advancement & Global Integration Thursday August 16, 6:54 pm ET OKLAHOMA CITY--(BUSINESS WIRE)--Dr. Ronald Shinn, President and Board of Directors' Chairman of ARTEC, Inc. (Pink Sheets:ATKJ - News), a company in the process of enterprising a revolutionary polysaccharide compound to be used as an HIV/AIDS and ANTI-CANCER immunostimulant, trade named TUBERCIN(TM), announces key appointments today. The company's goal with its new appointments is to initiate the production and global distribution of TUBERCIN(TM) and related immunostimulant medicines around the world. "Research and development of TUBERCIN(TM) is complete, requiring no further refinement or alteration in terms of its formulation. Our new business associates are joining ARTEC, Inc. in order to stimulate and enforce the production of this potentially promising immunostimulant to combat HIV and CANCER--bringing a source of hope and relief to the millions suffering with CANCER across the globe," said Dr. Ronald Shinn. "Our board members will utilize their invaluable experience in the areas of product enterprise, contract negotiations and strategic investments to insure that the production and distribution of TUBERCIN(TM) will develop in a way that is internationally accessible while remaining affordable." George E. Williams, Jr., Vice President of Hana Security Services, a company that provides civilian personnel for the U.S. Department of Defense throughout the United States has been appointed as an ARTEC, Inc. Director. Williams is also an experienced negotiator in working with governmental contracts throughout the world. Rodney Watson, Business Manager for Innovative Investment Holding PPY in Johannesburg, Republic of South Africa has been appointed Coordinator for ARTEC, Inc., South Africa. Watson is a successful business leader in South Africa along with other areas of Africa. He has been successfully responsible for overseeing large acquisitions and activating the funding of state-of-the-art technology projects. Cecil Thompson will now serve as Coordinator for ARTEC, Inc., Bahamas. He is currently President of Certified Consultants, Inc. Thompson brings an expertise in property development funding, mining and new business ventures. Gerry Knight, Executive Vice President for ARTEC, Inc., has been appointed as Coordinator for the Funding of Special Projects. Knight will focus on the development of the South Africa and Bahamas operations |
|
waterboy
Guest Group |
Post Options
Thanks(0)
|
ARTEC, INC. U
Artec, Inc. Of Reno, Nevada Announces Completing Its Patent Goals And Has Received The Final Patents From Canada And Western Europe That Were Pending (Cancer Treatment) RENO, NV., Sept. 27–ArTec, Inc., (Pink Sheets: ATKJ ) A Pharmaceutical Company announces completing its patent goals and receiving the final patents from Canada and Western Europe. On August 13, 2003, the Western European Patent consisting of United Kingdom, France, Spain, Germany and Italy was issued. On May 11, 2004, the patent from Canada was issued. The goals accomplished consist of five final Patents that ArTec, Inc. will utilize: 1. Canada patent issued May 11, 2004, registration number 2,293,821. 2. Western Europe patent issued August 13, 2003, registration number 0,991,773. 3. United States patent issued August 14, 2001, registration number 6,274,356. 4. South Korea patent issued October 29, 1998, registration number 173362. 5. Japan patent issued June 12, 1998, registration |
|
Fitz
Guest Group |
Post Options
Thanks(0)
|
The website is very interesting.Do they have a potential cure?
www.artec-inc.net |
|
Post Reply | |
Tweet
|
Forum Jump | Forum Permissions You cannot post new topics in this forum You cannot reply to topics in this forum You cannot delete your posts in this forum You cannot edit your posts in this forum You cannot create polls in this forum You can vote in polls in this forum |